Health Catalyst
HCAT
161 hedge funds and large institutions have $326M invested in Health Catalyst in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 64 increasing their positions, 52 reducing their positions, and 39 closing their positions.
133,617% more call options, than puts
Call options by funds: $16M | Put options by funds: $12K
23% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 52
0.8% more ownership
Funds ownership: 85.54% → 86.34% (+0.8%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
7% less funds holding
Funds holding: 174 → 161 (-13)
14% less capital invested
Capital invested by funds: $377M → $326M (-$51.7M)
31% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 39
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$20.7M |
| 2 |
Millennium Management
New York
|
+$7.6M |
| 3 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$5.46M |
| 4 |
Primecap Management
Pasadena,
California
|
+$1.96M |
| 5 |
JP Morgan Chase
New York
|
+$1.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$11.1M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.75M |
| 3 |
BCM
Bares Capital Management
Austin,
Texas
|
-$3.39M |
| 4 |
Goldman Sachs
New York
|
-$2.49M |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$1.85M |
HCAT Hedge Fund Activity: Q2 2024 in Review
161 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q2 2024, worth a combined $326M — down 14% from $377M a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of HCAT and 27 opened new positions — a net loss of 12 holders — while 52 trimmed existing stakes and 64 added.
The largest buyer was First Light Asset Management, adding an estimated $20.7M. The largest seller was Point72 Asset Management, cutting an estimated $11.1M.
- 161 institutional investors held Health Catalyst (HCAT) as of Q2 2024, down from 174 in Q1 2024.
- Funds reported $326M of Health Catalyst stock for Q2 2024, down 14% quarter-over-quarter.
- 27 funds opened new Health Catalyst positions in Q2 2024 and 39 closed out, a net change of -12 holders.
- The largest Health Catalyst buyer in Q2 2024 was First Light Asset Management, an estimated $20.7M added.
- The largest Health Catalyst seller in Q2 2024 was Point72 Asset Management, an estimated $11.1M sold.
Based on aggregated 13F filings for Q2 2024.